- In September 2024, Becton, Dickinson and Company (U.S.) completed the acquisition of Edwards Lifesciences Corporation's Critical Care product group, which has since been renamed BD Advanced Patient Monitoring, unlocking new value streams and strengthening BD’s portfolio of innovative connected care solutions
- In June 2024, bioMérieux (France) announced that its BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini received U.S. FDA Special 510(k) clearance along with a CLIA-waiver, enabling rapid multiplex PCR testing for five major respiratory and throat pathogens within approximately 15 minutes
- In January 2024, Wipro GE Healthcare a joint venture between GE Precision Healthcare LLC (U.S.) and Wipro Enterprises Limited (India) signed a memorandum of understanding (MoU) with the Indian Institute of Science (IISc) to advance healthcare innovation, research, and technology development in India
- In August 2023, Bio-Rad Laboratories, Inc. (U.S.) introduced two new products, PTC Tempo 48/48 and PTC Tempo 384, both designed to support PCR applications across basic research, translational science, process development, and quality control environments
- In May 2022, QuantuMDx Group Limited (U.K.), a leading provider of point-of-care diagnostics, launched its Q-POC SARS-CoV-2, Flu A/B & RSV Assay, a multiplex respiratory panel test designed to deliver rapid and accurate testing for respiratory viruses at the point of care
- In January 2022, Highmark Health and Bosch entered a strategic research partnership to develop AI-powered sensor technologies for detecting pediatric pulmonary conditions, such as asthma, building on traditional diagnostic practices with cutting-edge innovations
